Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Tropical Medicine and Hygiene|July 10, 2019
Case Report: Imported Melioidosis from Goa, India to Israel, 2018Tal Brosh-Nissimov, Daniel Grupel, Shlomi Abuhasira, et al.Scientific Reports|July 23, 2024
Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirementAvigayil Goldstein, Ami Neuberger, Yazeed Qassem Darawsha, et al.Open Forum Infectious Diseases|June 13, 2024
Varicella-Zoster Virus-Induced Neurologic Disease After COVID-19 Vaccination: A Multicenter Observational Cohort StudyMeital Elbaz, Tomer Hoffman, Dafna Yahav, et al.Scientific Reports|November 22, 2025
Colostrum from MERS-CoV seropositive camels for MERS prophylaxis and SARS-CoV-2 infection, a placebo controlled randomized trialHagit Masika, Meir Cherniak, Yelena Britan-Rosich, et al.MMWR. Morbidity and Mortality Weekly Report|December 11, 2025
Detection of Paraburkholderia in Clinical Specimens Associated with Use of Nonsterile Ultrasound Gel for Percutaneous Procedures - United States, Canada, and Israel, May 2023⎯April 2025Sarah Lim, Paula Snippes Vagnone, Natalie C Marshall, et al.Journal of the Pediatric Infectious Diseases Society|June 15, 2021
COVID-19 in a Subset of Hospitalized Children in IsraelShalom Ben-Shimol, Gilat Livni, Orli Megged, et al.Cancer Medicine|February 24, 2024
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximabTali Shafat, Daniel Grupel, Tzvika Porges, et al.Infectious Diseases and Therapy|December 9, 2024
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter StudyHovav Azuly, Tali Shafat, Daniel Grupel, et al.Pageof 3